These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38347480)

  • 1. Network pharmacology-based strategy to investigate the mechanisms of artemisinin in treating primary Sjögren's syndrome.
    Liao JH; He Q; Huang ZW; Yu XB; Yang JY; Zhang Y; Song WJ; Luo J; Tao QW
    BMC Immunol; 2024 Feb; 25(1):16. PubMed ID: 38347480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network Pharmacology Analysis and Experimental Validation to Investigate the Mechanism of Total Flavonoids of Rhizoma Drynariae in Treating Rheumatoid Arthritis.
    Chen GY; Luo J; Liu Y; Yu XB; Liu XY; Tao QW
    Drug Des Devel Ther; 2022; 16():1743-1766. PubMed ID: 35702063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Fangji Huangqi Tang as a potential herbal formula for Sjogren syndrome treatment via network pharmacology and experimental validation.
    Shao Y; Hu J; Wang S; Jiang H; Miao G; Li C; Zhang J; Xu Y
    Chem Biol Drug Des; 2023 Dec; 102(6):1435-1447. PubMed ID: 37640538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering potential pharmacological mechanism of Sha-Shen-Mai-Dong decoction on primary Sjogren's syndrome.
    Jiang Y; Zhao X; Yu J; Wang Q; Wen C; Huang L
    BMC Complement Med Ther; 2021 Mar; 21(1):79. PubMed ID: 33648502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network pharmacology identifies the inhibitory effect of Yiqiyangyinquyu prescription on salivary gland inflammation in Sjögren's syndrome.
    Hong T; Chen W; Ren YT; Wang YH; Lu DQ; Zhang KY; Yao XY; Wang XC
    Medicine (Baltimore); 2023 Nov; 102(47):e36144. PubMed ID: 38013284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sjögren's syndrome in NOD/Ltj mouse.
    Shi H; Yu CQ; Xie LS; Wang ZJ; Zhang P; Zheng LY
    J Oral Pathol Med; 2014 Nov; 43(10):785-91. PubMed ID: 25065264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin improves salivary gland damage and hypofunction in pSS by inhibiting IL-6/STAT3 signaling through its receptor-dependent manner.
    Liu Y; Wang F; Cheng B; Zhou G
    Mol Immunol; 2024 May; 169():10-27. PubMed ID: 38460474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncovering the molecular mechanism of Mume Fructus in treatment of Sjögren's syndrome.
    Sun Z; Deng L; Xu Z; Yang K; Yu P
    Medicine (Baltimore); 2024 May; 103(19):e38085. PubMed ID: 38728503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3K/AKT/mTOR Signaling Pathway Is Downregulated by Runzaoling (RZL) in Sjögren's Syndrome.
    Zeng P; Jiang Z; Huang Z; Huang Y; Xu H; Chen C; Ma W
    Mediators Inflamm; 2022; 2022():7236118. PubMed ID: 36133744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
    Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fangchinoline Inhibited Proliferation of Neoplastic B-lymphoid Cells and Alleviated Sjögren's Syndrome-like Responses in NOD/Ltj Mice via the Akt/mTOR Pathway.
    Shao Y; Fu J; Zhan T; Ye L; Yu C
    Curr Mol Pharmacol; 2022; 15(7):969-979. PubMed ID: 35176991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-H4 Inhibits the Development of Primary Sjögren's Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice.
    Zheng X; Wang Q; Yuan X; Zhou Y; Chu H; Wang G; Li X; Wang Y; Wei L; Wang L; Li X
    J Immunol Res; 2020; 2020():4896727. PubMed ID: 33062721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
    Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose interleukin-2 can improve salivary secretion but not lymphocyte infiltration of salivary glands in a murine model of Sjögren's syndrome.
    Wen J; Zhu F; Yu X; Xie H; Li C
    BMC Immunol; 2022 Oct; 23(1):49. PubMed ID: 36244973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the mechanisms of action of Zengye decoction (ZYD) against Sjogren's syndrome (SS) using network pharmacology and animal experiment.
    Yu J; Wang S; Yang J; Huang W; Tang B; Peng W; Tian J
    Pharm Biol; 2023 Dec; 61(1):1286-1297. PubMed ID: 37606264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Lushi Runzao decoction on ameliorating Sjogren's syndrome: a network pharmacology and experimental verification-based study.
    Fengtao P; Kesong LI; Yi Z; Xiaopo T; Xinyao Z
    J Tradit Chin Med; 2023 Aug; 43(4):751-759. PubMed ID: 37454260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1/STAT3 pathway in primary Sjögren's syndrome.
    Hu P; Cai J; Yang C; Xu L; Ma S; Song H; Yang P
    Int Immunopharmacol; 2024 Jan; 126():111282. PubMed ID: 38061117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
    Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
    Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling.
    Zhan T; Wang B; Fu J; Shao Y; Ye L; Shi H; Zheng L
    Phytomedicine; 2021 Jan; 80():153381. PubMed ID: 33086170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.